Seoul National University Hospital

Medicine & Life Sciences

1. Korea 100%
2. Neoplasms 72%
3. Stomach Neoplasms 51%
4. Survival 48%
5. Therapeutics 45%
6. Confidence Intervals 39%
7. Hepatocellular Carcinoma 37%
8. Breast Neoplasms 37%
9. Recurrence 33%
10. Genes 32%
11. Republic of Korea 32%
12. Child 32%
13. Neoplasm Metastasis 29%
14. Population 28%
15. Safety 28%
16. Mutation 28%
17. Liver 28%
18. Drug Therapy 27%
19. Odds Ratio 25%
20. Magnetic Resonance Imaging 25%
21. Cohort Studies 24%
22. Tomography 24%
23. Seoul 24%
24. Kidney 22%
25. Incidence 22%
26. Serum 22%
27. Multicenter Studies 22%
28. Lung 22%
29. Mortality 22%
30. Pediatrics 21%
31. Stomach 21%
32. Lymph Nodes 20%
33. Non-Small Cell Lung Carcinoma 20%
34. Brain 20%
35. Stents 19%
36. Stroke 19%
37. Colorectal Neoplasms 18%
38. Skin 18%
39. Radiotherapy 18%
40. Carcinoma 18%
41. Transplants 18%
42. Retrospective Studies 18%
43. Registries 17%
44. Randomized Controlled Trials 16%
45. Progression-Free Survival 16%
46. Meta-Analysis 16%
47. Prospective Studies 16%
48. Pharmacokinetics 16%
49. Eye 16%
50. Breast 15%
51. Proteins 15%
52. Genotype 15%
53. Liver Transplantation 15%
54. Positron-Emission Tomography 15%
55. Multivariate Analysis 14%
56. Biopsy 14%
57. Biomarkers 14%
58. Apoptosis 14%
59. Bone and Bones 14%
60. Gastrectomy 14%
61. Survival Rate 13%
62. Elderly 13%
63. Quality of Life 13%
64. Adenocarcinoma 13%
65. Cell Line 13%
66. Lung Neoplasms 13%
67. Hemorrhage 13%
68. Wounds and Injuries 13%
69. Inflammation 12%
70. Growth 12%
71. Ultrasonography 12%
72. Asthma 12%
73. Healthy Volunteers 12%
74. Guidelines 12%
75. Myocardial Infarction 12%
76. Fluorodeoxyglucose F18 12%
77. Thorax 12%
78. Pharmaceutical Preparations 12%
79. Placebos 12%
80. Injections 12%
81. Control Groups 12%
82. Helicobacter pylori 12%
83. Single Nucleotide Polymorphism 11%
84. University Hospitals 11%
85. Alzheimer Disease 11%
86. Renal Cell Carcinoma 11%
87. Pathologic Constriction 11%
88. Uterine Cervical Neoplasms 11%
89. Body Mass Index 11%
90. Living Donors 11%
91. Regression Analysis 11%
92. Arteries 11%
93. Phenotype 11%
94. Schizophrenia 11%
95. Pain 11%
96. Glucose 11%
97. Chronic Renal Insufficiency 11%
98. Observational Studies 11%
99. Logistic Models 11%
100. Magnetic Resonance Spectroscopy 11%